Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD4SL
|
||||
| Drug Name |
1-phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)propan-1-ol
|
||||
| Synonyms |
CHEMBL135712
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C17H22N4O
|
||||
| Canonical SMILES |
OC(CCN1CCN(CC1)c2ncccn2)c3ccccc3
|
||||
| InChI |
InChI=1S/C17H22N4O/c22-16(15-5-2-1-3-6-15)7-10-20-11-13-21(14-12-20)17-18-8-4-9-19-17/h1-6,8-9,16,22H,7,10-14H2
|
||||
| InChIKey |
GNEPRYRWYXNGOT-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.